Rheumatology Cases for the Internist

Similar documents
CHAPTER:2 GOUT. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.

Gout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout

Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

EARLY INFLAMMATORY ARTHRITIS. Cristina Tacu Consultant Rheumatologist Brighton and Sussex University Hospital

Gout A rapid review. Jeremy Jones

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011

Gout -revisited. Shrenik Shah

A Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.

Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD

Spondyloarthritis: A Gouty Display

Patient #1. Rheumatoid Arthritis. Rheumatoid Arthritis. 45 y/o female Morning stiffness in her joints >1 hour

COPYRIGHT. Update in Internal Medicine December 4, 2016

Arthritis. that affects the joints.

Rheumatology Updates for the Primary Care Provider

When is it Rheumatoid Arthritis When to Refer

SLE-key Case Studies

Case presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg

A case of extensive synovial involvement by tophaceous gout

APPROACH TO PATIENTS WITH POLYARTHRALGIA

Gout. Crystal deposition disease: Imaging perspectives. Crystal associated arthropathies. Clinical Stages of Gout 07/06/60

Managing Gout A Review of the Research for Adults

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis

Index. Note: Page numbers of article titles are in boldface type.

Understanding Rheumatoid Arthritis

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)

Dual energy CT in diagnosis of Gout

Initial Phase 3 Studies Results for Rilonacept in the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapy and the Treatment

MONOSODIUM URATE CRYSTALS IN THE KNEE JOINTS OF PATIENTS WITH ASYMPTOMATIC NONTOPHACEOUS GOUT

Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP

I nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide

Mono-articular Joint Complaints

Gout basics. Update on Gout. Production of uric acid. Gout basics. Crystal induced inflammation. Gout calculator. The important role of ultrasound

Disclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.

Rheumatology for the Nurse Practitioner. Mary Derlacki, FNP Eugene Rheumatology

Acute hot swollen joint. Dr Edward Roddy Senior Lecturer in Rheumatology and Consultant Rheumatologist

A CRP B FBC C LFT D blood culture E uric acid

Missed, Misdiagnosed & Mistreated: De-Mystifying Three Common Rheumatic Diseases

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

GOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R.

What organ system is involved? What is the pathology? What is the possible etiology?

Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout

FIBROMYALGIA ANNE WINKLER MD PHD MO ACP MEETING SEPT 2016

Kelley's Textbook of Rheumatology. 2 Volume Set. Text with Internet Access Code for Premium Consult Edition

REFERRAL GUIDELINES: RHEUMATOLOGY

Crystal induced arthropathies. Dr. Amitesh Aggarwal

Coverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication

Clinical Practice Guideline. Gout. Version

Ultrasound in Rheumatology

ELENI ANDIPA General Hospital of Athens G. Gennimatas

Gout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Original Article Clinical Registry For Rheumatoid Arthritis Pak Armed Forces Med J 2017; 67 (2):

GOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds

Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018

Gout Hanan Abdel Rehim

Inflammatory rheumatic diseases

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis

Crystal-Induced Arthritis. Rajesh Kataria, D.O. Southern Ohio Rheumatology

Pharmacological Management of Knee Pain

Krystexxa (pegloticase) Document Number: IC-0158

Zurampic, Duzallo (lesinurad Products)

BSR Biologics Register Rheumatoid Arthritis Clinical Baseline Form

Clinical Practice Guideline. Ultrasound in Rheumatological Settings. Version

GOUT. Dr Krishnan Baburaj West herts NHS Trust

Subject: Krystexxa (pegloticase) Original Effective Date: 06/26/13. Policy Number: MCP-138. Revision Date(s):

Rheumatology Objec1ves. Rheumatology Objec1ves By the end of this presenta1on, the a<endee should be able to: 5/5/11

Limitations of Use: (1) Duzallo is not recommended for the treatment of asymptomatic hyperuricemia.

Enhanced Primary Care Pathway: Gout

New Drug Evaluation: lesinurad tablet, oral

Joint Injuries and Disorders

9/20/17. Fibromyalgia Case Discussion. Objectives. Disclosure

Rheumatology Pearls 1) A detailed history is much more useful in the work up of patients with inflammatory peripheral arthritis than any lab tests.

Hths 2231 Laboratory 13 Alterations in Musculoskeletal

History Taking and the Musculoskeletal Examination

Drugs Used to Treat Gout. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Rheumatoid Arthritis

Rheumatoid Arthritis

DISCUSSION BY: Dr M. R. Shakeebi, MD, Rheumatologist

Update on Gout for GPs

Rheumatology 101 A Pediatrician s Guide

The Johns Hopkins Hospital

ACP Rheumatology Pearls. Adam Q Carlson MD Assistant Professor UVA Rheumatology

Long-term Treatment of Gout: New Opportunities for Improved Outcomes

2) An 87 year old female who is 2 weeks post TKR presents with a sore swollen knee. She has a history of atrial fibrillation. Her vital signs are:

Rheumatology Potpourri. Dr. Philip A. Baer Seacourses Asia CME December 2017

Gout Treatment Guidelines

Lecture 8 Gout Hinch. Pathogenesis of acute attacks

Bursitis. Other joints are found between the different bones of your fingers and toes. You also have joints that allow your vertebrae to move.

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed:

Case Based Rheumatology STEVE S LEE, DO FACR SCPMG FONTANA

ERROR CORRECTION FORM

What will happen in the future? How will gout be diagnosed? How is gout treated? prevent

Essence of the Revised Guideline for the Management of Hyperuricemia and Gout

Zurampic. (lesinurad) New Product Slideshow

FIBROMYALGIA. Howard L. Feinberg, D.O. F.A.C.O.I., F.A.C.R. OPSC San Diego 2017

Quality measures in osteoarthritis

OBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE

Transcription:

Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School of Medicine Director, Medical Care Clinical Center VA Maryland Health Care System

Objectives To present and discuss three cases that represent the most common reasons for referral to my academic rheumatology practice at both the University of Maryland and Baltimore VA Medical Center.

Case 1: History 45-year-old woman who presents for evaluation of polyarticular joint pain of several years duration. She admits to AM stiffness lasting ~1 hour, gel phenomenon, but denies joint swelling or redness. Review of systems is positive for difficulty falling asleep, difficulty staying asleep, snoring, fatigue and diffuse myalgias; pertinent negatives include lack of fever or weight loss.

Case 1: History There is no h/o sicca symptoms, rash, mucosal ulcers, Raynaud phenomenon or Lyme disease. Family history is non-contributory. Social history is positive for modest alcohol consumption (average 4 drinks per week), former smoker, no illegal drug use. She lives in Baltimore City and currently works as an administrative assistant.

Case 1: Physical Examination Normal vital signs No evidence of active or chronic synovitis, joint effusions or deformity. Normal muscle strength. Tender at 14/18 tender points. Remainder of examination, including neurologic exam, is within normal limits.

Fibromyalgia: Treatment Non-pharmacologic modalities Patient education, good sleep hygiene, cognitive behavioural therapy and aerobic exercise program; consider acupuncture, tai chi and/or yoga Pharmacologic modalities Amitriptyline or cyclobenzaprine followed by duloxetine or milnaciprin, pregabalin or a combination of the above Avoid opioid analgesics!

2017 EULAR Management Recommendations. 2017 by BMJ Publishing Group Ltd and European League Against Rheumatism G J Macfarlane et al. Ann Rheum Dis 2017;76:318-328

Case 1: Questions

Case 2: History 45-year-old woman who presents for evaluation of polyarticular joint pain of several months duration. She admits to AM stiffness lasting ~1 hour, gel phenomenon and joint swelling with difficulty performing her usual daily activities. Review of systems is positive for fatigue, depressed mood, low grade fever, anorexia and weight loss.

Case 2: History Positive for h/o sicca symptoms; however, she denies rash, mucosal ulcers, chest pain, muscle weakness or Raynaud phenomenon. Family history is positive for RA in her mother. Social history is positive for modest alcohol consumption (average 4 drinks per week), current smoking, but no illegal drug use. She lives in Baltimore County and currently works as an administrative assistant.

Case 2: Physical Examination Normal vital signs Combination of both active and chronic synovitis involving all PIP and MCP joints of both hands and both wrists as well as tenderness across MTP joints of the feet bilaterally. Normal proximal muscle strength; however, grip strength is reduced bilaterally. No subcutaneous nodules or skin rash Remainder of examination, including neurologic exam, is within normal limits.

16

18

Case 2: Laboratory Evaluation CBC with differential Chemistry profile Acute phase reactants Serology Rheumatoid factor Anti-citrullinated peptide antibodies (ACPA)

Definite Case 2: Imaging Evaluation Plain radiographs of affected joints Possible Color Doppler ultrasound Magnetic resonance imaging

22

RA: Approach to Management Refer to rheumatologist! All patients with active RA should receive a disease-modifying antirheumatic drug (DMARD) All patients should receive non-pharmacologic modalities including patient education, OT/PT NSAIDs and glucocorticoids are adjunctive agents for control of symptoms

Case 2: Questions

Case 3: History 45-year-old man who presents for evaluation of polyarticular joint pain and swelling involving the left foot/ankle, right knee and wrist of several weeks duration. He has a h/o recurrent episodic monoarthritis previously involving the big toe bilaterally, left ankle and right elbow. These were previously treated with OTC NSAIDs; he has never had a joint aspirate or been treated with colchicine or urate lowering therapy. Review of systems is positive for low grade fever and anorexia.

Case 3: History Positive for h/o hypertension treated with HCTZ and lisinopril, and hyperlipidemia treated with simvastatin. Family history is positive for kidney stone and gout in his father. Social history is positive for moderate alcohol consumption (average 10 drinks per week), current smoking, but no illegal drug use. He lives in Baltimore County and formerly worked at Bethlehem Steel.

Case 3: Physical Examination Normal vital signs Combination of active synovitis involving left foot and ankle, right knee and right wrist with warmth, tenderness and soft-tissue swelling; right knee effusion present with positive bulge sign. Subcutaneous nodule in right olecranon bursa. Remainder of examination is within normal limits.

Correct Nomenclature Gout is a chronic inflammatory arthritis that results from monosodium urate (MSU) crystal deposition in tissues or joints resulting from supersaturation of uric acid in extracellular fluids Gout is a disorder of uric acid metabolism Hyperuricemia is defined as serum uric acid >2 SD above the mean (> 7.0 mg/dl for men, > 6.0 mg/dl for women) Hyperuricemia is a necessary but not sufficient precursor to gout

Gout: Stages Asymptomatic hyperuricemia Acute episodic monoarthritis Intercritical gout Chronic polyarthritis, often with tophaceous deposits

Case 3: Evaluation Laboratory tests CBC with differential Chemistry profile, including serum uric acid Acute phase reactants Imaging Plain radiography Ultrasonagrapy (double contour sign) Dual-energy CT

Gout: Treatment of Arthritis Treat acute/chronic arthritis Colchicine NSAIDs Glucocorticoids IL-1 inhibition

Gout: Prevention of Recurrent Attacks Oral colchicine Urate lowering therapy Xanthine oxidase inhibition Allopurinol Febuxostat Uricosuric agents Probenecid Lesinurad (Zurampic TM ) specific URAT1 inhibitor

Case 3: Questions

Choosing Wisely: Rheumatology Don t test ANA sub-serologies unless the ANA is positive in a clinically significant titer Don t test for Lyme disease without an exposure history and appropriate exam findings Don t perform MRI of the peripheral joints to monitor inflammatory arthritis Don t prescribe biologic DMARDs for RA before a trial of MTX or other conventional DMARD American College of Rheumatology. Released February 21, 2013.

Rheumatology Referral Guidelines Evaluation of patients with unclear diagnoses Evaluation and management of patients with Inflammatory arthritis Systemic autoimmune rheumatic diseases Connective tissue diseases and vasculitides Diagnostic or treatment plan for rheumatic manifestations of other primary diseases Approved by ACR Board of Director, August 2015 (modified by MCH)

Thank you for your kind attention.